Roberto Hoornweg
CIK: 0002053363
Associated companies
Transaction History
| MKTX | ▲ Buy | Grant | 1,390 | $0 | 6/10/2026 | View on chart |
| MKTX | ▲ Buy | Grant | 784 | $0 | 6/4/2025 | View on chart |
| MKTX | ▲ Buy | Grant | 215 | $0 | 3/1/2025 | View on chart |
| MKTX | ▲ Buy | Grant | 1,390 | $0 | 6/10/2026 | View on chart |
| MKTX | ▲ Buy | Grant | 784 | $0 | 6/4/2025 | View on chart |
| MKTX | ▲ Buy | Grant | 215 | $0 | 3/1/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
MarketAxess Reports Q2 Earnings and New Data Integration
MarketAxess released its Q2 earnings, showing the company’s performance in the fixed‑income market. The firm also announced that Arcesium will use more MarketAxess data and analytics to improve fixed‑income workflows, which could broaden its reach. Analysts note that while the stock is trading near the top of its 52‑week range, it is compared to BGC as a potential value play, and some analysts warn it could drop sharply in October.
MarketAxess Reports Q2 Earnings and New Data Integration. MarketAxess released its Q2 earnings, showing the company’s performance in the fixed‑income market. The firm also announced that Arcesium will use more MarketAxess data and analytics to improve fixed‑income workflows, which could broaden its reach. Analysts note that while the stock is trading near the top of its 52‑week range, it is compared to BGC as a potential value play, and some analysts warn it could drop sharply in October.